TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Maximum tolerated dose (MTD) or recommended dose in subsequent clinical trials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicide remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of KIR3DL2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival based on PSA response
Endpoint domain: Mortality/survival
Primary endpoint: Change in intratumoral density of immunosuppressive T-regulatory (FOXP3+) cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in intratumoral density of M2 tumor-associated macrophages (CD163+ cells)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neonatal Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline total energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number and percentage of subjects reporting solicited local and systemic signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of subjects reporting unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical response to diuretic therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rehospitalization event prediction
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dynamics of rehabilitation routing status score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dynamics of Barthel status score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dynamics of EQ5 status score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Brain natriuretic peptide level in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sexual Quality of Life-Female
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of urinary complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Whitening Potential of Mineral Sunscreens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Acute post nephrectomy pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time average wall shear stress (TAWSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Epidural rescue doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Anxiety level of the expectant mother
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal attachment of the expectant mother
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety level of the expectant father
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Paternal attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in circulating biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in iron content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of people who are eligible
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of consented participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants who report using the e-cigarette at least once a day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with long term oxygen therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work efficiency
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Montgomery Åsberg Depression Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety levels measured by the Beck Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportions of correct predictions for location of arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportions of correct predictions for mechanism of arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Working Memory as measured by the WAIS-IV Digit Span Forward/Backward
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Working Memory as measured by the TMT-B
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Working Memory as measured by Category Fluency Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Transplantation Related Mortality (TRM)
Endpoint domain: Mortality/survival
Primary endpoint: Frequency and severity of clinical AEs and laboratory parameters
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically detectable malignancy and/or abnormal clonal dominance assessed as related to study treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patient Health Questionnaire (PHQ-9)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic yield of intraoperative histological analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in fatigue impact
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 6 Month Retear Rate
Endpoint domain: Adverse events/effects
Primary endpoint: The number of subjects experiencing adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: WHO-5 Well-Being Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative Fluid Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Scalp Photographic Index (SPI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of Best Corrected Visual Acuity (BCVA) in ETDRS letter score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Helicobacter pylori Eradication Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Airway microbial profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Airway pro-inflammatory and pro-fibrotic gene expression profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Airway immune cellular profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Serious Adverse Events related to study drug
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of NUC and CD
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of the target regional cerebral blood flow (rCBF) anomaly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of the functional connectivity anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of successful management of maternal hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Noradrenaline doses administered and total dose amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of portable ultrasound
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Femoral anteversion angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip agonist-antagonist muscle ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized frequency of asthma step-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electroencephalographic (EEG) oscillatory amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalographic (EEG) oscillatory frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalographic (EEG) oscillatory phase coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Autism Quotient (AQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Schizotypal Personality Questionnaire (SPQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hemoglobin level in g/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HBA1C level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rankin Scale (RS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SADE-free rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HbA1c level (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients completing colonoscopy or Cologuard test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction of antidepressant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change from Baseline Speed of Information Processing score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent Change from Attention/Vigilance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent Change from Working Memory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: SARS-Cov-2 Viral Load at Day 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Grade 3 or above Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Delirium Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Delirium Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator-assessed objective response rate (ORR) per RECIST 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SMART Risk Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding on Probing
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of asyncronies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of tau measured by SUVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Log-ratio of Dialister to Lactobacillus crispatus relative abundances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Microbial outcomes
Primary endpoint: Parkinson's disease symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization or Emergency Department Visit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Clinical Global Impressions Scale - Improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient Health Questionnaire - 9 - M
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in OFF Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of netupitant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite adverse pregnancy and neonatal outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Mothers with Postpartum Depression (PPD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: tTG antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in quality of life (change in Celiac Disease Quality of Life scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Trial Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Trial Retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Variation of LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Biodistribution of 68Ga-NY104 in normal organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor uptake of 68Ga-NY104
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of PSCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disorganized speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Favorable functional outcome at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Site of service rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Static postural balance as quantified by center of pressure parameters (COP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical excitability as evaluated by Active Motor Threshold (AMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC 0-168 hour (h) for NNC0194-0499
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC 0-168 hour (h) for semaglutide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for NNC0194-0499
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for semaglutide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in myocardial flow reserve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Knee Extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Ankle Plantarflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Elbow Extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean score connectedness rating
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean score subjective rating of synchrony
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intracranial objective response rate (ORR-IC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival (OS) rate at 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Pretest Transcription Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttest Transcription Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrectus distance measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to 12-point decrease in ALSFRS-R or death
Endpoint domain: Mortality/survival
Primary endpoint: Intervention attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Red blood cell microparticles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemoglobinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Creatinine three days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: EVANpedia Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in the average number of handling errors per inhalation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Asthma Control Test (ACT) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood loss during menses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration and severity of dysmenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromuscular Recovery Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in molecular, radiologic, and pathologic hallmarks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sequencing of treatment regimens
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Leukemia Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: clinical and radiological outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Acute Myeloid Leukemia (AML) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and type of treatment-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of women who availed at least three Antenatal Care (ANC) visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of women who delivered at institution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of women who received post-natal care within a week of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in target lesion CLASI-A score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness of POD (Post-operative Delirium)
Endpoint domain: Adverse events/effects
Primary endpoint: Awareness of POCD (Post-operative Cognitive Dysfunction)
Endpoint domain: Adverse events/effects
Primary endpoint: Latency from Enrollment to Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental cost per avoided complication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error rate in peripheral intravenous infusion device selection
Endpoint domain: Adverse events/effects
Primary endpoint: Working Memory Brain Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Working Memory Brain Functional Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in oral pain medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum Plasma Concentration (Cmax) Levels of JZP441
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Plasma Concentration (Tmax) of JZP441
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in loneliness levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of glycated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: One-year RFS
Endpoint domain: Mortality/survival
Primary endpoint: Three-year RFS
Endpoint domain: Mortality/survival
Primary endpoint: Identification of CNV or SNV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Diagnosed with Maternal Sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of Stroke, Systemic Embolic Events, Major Bleeding, or All-Cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Smoking Self-Efficacy Questionnaire (SEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Objective patient functional capacity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Understandability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Actionability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of MeTree Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Implementation Strategy Usability Scale (ISUS) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Participant Responsiveness Scale (PRS) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Patient Health Questionnaire (PHQ-9) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Quality of Life in Neurological Disorders Social Relations scale (Neuro-QOL) score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Multiple Sclerosis Quality of Life Scale (MSSQL-54)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Unnecessary Cesarean Section
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Lung Cancer Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage accuracy of fit with AUC of the ROC curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes